Company Filing History:
1 out of 486 
1 out of 2,355 
Years Active: 2014
Title: Yufeng Chen: Innovator in Cancer Treatment and Neurological Diseases
Introduction
Yufeng Chen is a notable inventor based in Jinhua, China. He has made significant contributions to the field of medical science, particularly in the development of innovative treatments for cancer and neurological diseases. His work has the potential to impact the lives of many patients suffering from these conditions.
Latest Patents
Yufeng Chen holds a patent for isoform-selective HDAC inhibitors. This invention focuses on methods to sensitize cancer cells to the cytotoxic effects of radiotherapy. Additionally, it provides methods for treating cancer, neurological diseases, and malaria. The invention also includes pharmaceutical compositions that comprise an HDAC inhibitor and kits containing the HDAC inhibitor.
Career Highlights
Throughout his career, Yufeng Chen has worked with prestigious institutions such as Georgetown University and the University of Illinois. His research has been pivotal in advancing the understanding and treatment of various diseases.
Collaborations
Yufeng Chen has collaborated with notable colleagues, including Alan P. Kozikowski and Mira Jung. These partnerships have contributed to the success of his research and innovations.
Conclusion
Yufeng Chen's work in developing isoform-selective HDAC inhibitors showcases his commitment to advancing medical science. His contributions have the potential to lead to significant improvements in cancer treatment and the management of neurological diseases.